LU Ventures
VC Fund
Lund, Sweden
LU Ventures is a VC fund in Lund focused on Medical and SaaS. LU Ventures, part of Lund University Innovation, co-founds spin-off companies with university researchers to commercialize research and drive global impact. It supports academics in building companies while allowing them to stay in academia, funding IP costs, recruiting CEOs/CTOs and board experts, and establishing legal/financialframeworks to attract external capit
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries LU Ventures invests in
Stages LU Ventures invests in
Countries LU Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Venture - Series Unknown
- $336k–$1.6M
Investment Focus
Industry
- Medical 2 (67%)
- SaaS 1 (33%)
- Software 1 (33%)
- Wireless 1 (33%)
- Simulation 1 (33%)
Stage
- Venture - Series Unknown 2 (67%)
- Pre-Seed 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Christine Widstrand
Chief Executive Officer
|
Chief Executive Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Waveium
|
Waveium develops a cloud-based SaaS platform that provides instant wireless design simulations and validation for engineers and wireless developers. The platform enables users to test and optimize wireless systems in real time using scalable, automated simulations. It exposes functionality through an API so teams can integrate wireless performancetesting into network planning, product development workflows, and AI training pipelines. Waveium focuses on reducing the time and cost of traditional measurement-based wireless validation while supporting experimentation with new wireless features. | $533.6K / Pre-Seed / Jun 24, 2026 | |
|
|
Aventera Antibodies is developing a first-in-class precision immunotherapy aimed at combating invasive Group A Streptococcal disease, a severe and often life-threatening bacterial infection. By leveraging advanced antibody engineering and targeted immune modulation, the company seeks to create a highly specific treatment that can neutralize thepathogen while minimizing damage to healthy tissues. | $1.6M / Venture - Series Unknown / Apr 28, 2026 | |
|
|
Cyclicor is an innovations based company focused on the development and commercialisation of safer and more sustainable polymers. The company was registered in October of 2012 as a spin-off company from the University of Lund in Sweden and began commercial development of its first product Cycli-ClearTM, a bisphenol free polycarbonate, in late 2013. | $336.3K / Venture - Series Unknown / Nov 10, 2025 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does LU Ventures invest in?
LU Ventures invests primarily in Medical, SaaS and Software startups, most often at Venture - Series Unknown and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is LU Ventures's check size?
LU Ventures typically joins rounds of $336k–$1.6M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds LU Ventures participates in.
How do I contact LU Ventures?
Public channels for LU Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at LU Ventures?
The team at LU Ventures includes Christine Widstrand (Chief Executive Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!